Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination with Trastuzumab Deruxtecan in Patients with HER2 Low/ultra-Low/null Metastatic Breast Cancer
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined